Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05484206 |
|
Recruitment Status :
Recruiting
First Posted : August 2, 2022
Last Update Posted : May 3, 2024
|
Sponsor:
Vir Biotechnology, Inc.
Information provided by (Responsible Party):
Vir Biotechnology, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 25, 2026 |
| Estimated Study Completion Date : | April 30, 2027 |